BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35984888)

  • 1. Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods.
    Katz DH; Robbins JM; Deng S; Tahir UA; Bick AG; Pampana A; Yu Z; Ngo D; Benson MD; Chen ZZ; Cruz DE; Shen D; Gao Y; Bouchard C; Sarzynski MA; Correa A; Natarajan P; Wilson JG; Gerszten RE
    Sci Adv; 2022 Aug; 8(33):eabm5164. PubMed ID: 35984888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling.
    Pietzner M; Wheeler E; Carrasco-Zanini J; Kerrison ND; Oerton E; Koprulu M; Luan J; Hingorani AD; Williams SA; Wareham NJ; Langenberg C
    Nat Commun; 2021 Nov; 12(1):6822. PubMed ID: 34819519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale plasma proteomics comparisons through genetics and disease associations.
    Eldjarn GH; Ferkingstad E; Lund SH; Helgason H; Magnusson OT; Gunnarsdottir K; Olafsdottir TA; Halldorsson BV; Olason PI; Zink F; Gudjonsson SA; Sveinbjornsson G; Magnusson MI; Helgason A; Oddsson A; Halldorsson GH; Magnusson MK; Saevarsdottir S; Eiriksdottir T; Masson G; Stefansson H; Jonsdottir I; Holm H; Rafnar T; Melsted P; Saemundsdottir J; Norddahl GL; Thorleifsson G; Ulfarsson MO; Gudbjartsson DF; Thorsteinsdottir U; Sulem P; Stefansson K
    Nature; 2023 Oct; 622(7982):348-358. PubMed ID: 37794188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
    Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.
    Katz DH; Tahir UA; Bick AG; Pampana A; Ngo D; Benson MD; Yu Z; Robbins JM; Chen ZZ; Cruz DE; Deng S; Farrell L; Sinha S; Schmaier AA; Shen D; Gao Y; Hall ME; Correa A; Tracy RP; Durda P; Taylor KD; Liu Y; Johnson WC; Guo X; Yao J; Ida Chen YD; Manichaikul AW; Jain D; Bouchard C; Sarzynski MA; Rich SS; Rotter JI; Wang TJ; Wilson JG; Natarajan P; Gerszten RE;
    Circulation; 2022 Feb; 145(5):357-370. PubMed ID: 34814699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond antibodies: new affinity reagents to unlock the proteome.
    Lollo B; Steele F; Gold L
    Proteomics; 2014 Mar; 14(6):638-44. PubMed ID: 24395722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients.
    Liu RX; Thiessen-Philbrook HR; Vasan RS; Coresh J; Ganz P; Bonventre JV; Kimmel PL; Parikh CR
    Transl Res; 2021 Dec; 238():49-62. PubMed ID: 34343625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative selection and parallel characterization of aptamers.
    Cho M; Soo Oh S; Nie J; Stewart R; Eisenstein M; Chambers J; Marth JD; Walker F; Thomson JA; Soh HT
    Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18460-5. PubMed ID: 24167271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits.
    Nayor M; Short MI; Rasheed H; Lin H; Jonasson C; Yang Q; Hveem K; Felix JF; Morrison AC; Wild PS; Morley MP; Cappola TP; Benson MD; ; ; Ngo D; Sinha S; Keyes MJ; Shen D; Wang TJ; Larson MG; Brumpton BM; Gerszten RE; Omland T; Vasan RS
    Circ Heart Fail; 2020 May; 13(5):e006749. PubMed ID: 32408813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates.
    Beutgen VM; Bhagwat AM; Steitz AM; Reinartz S; Müller R; Graumann J
    Anal Chem; 2024 Jun; 96(23):9332-9342. PubMed ID: 38810147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical biochips for protein analysis.
    Warsinke A
    Adv Biochem Eng Biotechnol; 2008; 109():155-93. PubMed ID: 17928973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.
    Dubin RF; Rhee EP
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):404-411. PubMed ID: 31636087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Large-Scale Semiquantitative Proteomic Data Stability Across Multiple Instrument Platforms.
    Lu C; Glisovic-Aplenc T; Bernt KM; Nestler K; Cesare J; Cao L; Lee H; Fazelinia H; Chinwalla A; Xu Y; Shestova O; Xing Y; Gill S; Li M; Garcia B; Aplenc R
    J Proteome Res; 2021 Nov; 20(11):5203-5211. PubMed ID: 34669412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput proteomics using antibody microarrays.
    Wingren C; Borrebaeck CA
    Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study.
    Rooney MR; Chen J; Ballantyne CM; Hoogeveen RC; Tang O; Grams ME; Tin A; Ndumele CE; Zannad F; Couper DJ; Tang W; Selvin E; Coresh J
    Clin Chem; 2023 Jan; 69(1):68-79. PubMed ID: 36508319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide aptamers: development and applications.
    Reverdatto S; Burz DS; Shekhtman A
    Curr Top Med Chem; 2015; 15(12):1082-101. PubMed ID: 25866267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-based proteomics for human tissue profiling.
    Uhlen M; Ponten F
    Mol Cell Proteomics; 2005 Apr; 4(4):384-93. PubMed ID: 15695805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Proteomic Assessment Methods in Multiple Cohort Studies.
    Raffield LM; Dang H; Pratte KA; Jacobson S; Gillenwater LA; Ampleford E; Barjaktarevic I; Basta P; Clish CB; Comellas AP; Cornell E; Curtis JL; Doerschuk C; Durda P; Emson C; Freeman CM; Guo X; Hastie AT; Hawkins GA; Herrera J; Johnson WC; Labaki WW; Liu Y; Masters B; Miller M; Ortega VE; Papanicolaou G; Peters S; Taylor KD; Rich SS; Rotter JI; Auer P; Reiner AP; Tracy RP; Ngo D; Gerszten RE; O'Neal WK; Bowler RP;
    Proteomics; 2020 Jun; 20(12):e1900278. PubMed ID: 32386347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.